This study looked at patients infected with a specific type of gut bacteria called OXA-48. Researchers combined data from many different medical centers in France and other places. They compared how well carbapenem drugs worked against newer treatment options.
The results were not good for patients getting carbapenems. About half of these patients died within thirty days. When doctors used only meropenem, a type of carbapenem, more than half of the patients did not get better. This suggests the drug did not work as expected.
When looking at all available studies, patients on newer drugs had much lower death rates. The chance of dying was about thirty percent lower with these new medicines. Also, patients were less likely to fail treatment when given these alternative options instead of carbapenems.
Doctors should try to use these newer medicines whenever they are available. Carbapenems might look like they work in lab tests, but they often fail in real patients. Using the best available drugs gives patients the best chance to survive and recover quickly.
